Anti-prolactin treatment alleviates lupus conditions by regulating the JAK2-STAT3 pathway.
Clinical and experimental pharmacology & physiology（2023）
Abstract
In summary, these data suggest that PRL inhibition alleviates lupus-like disease in MRL/lpr mice by modulating the Jak2-Stat3 signalling cascade. More importantly, our results imply the potential of PRL inhibitors and may provide a novel therapeutic approach for lupus.
MoreTranslated text
Key words
lupus conditions
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined